Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 55,499	$ 126,590
Marketable securities, current	189,405	127,091
Accounts receivable	3,102	11,799
Prepaid expenses and other current assets	9,761	5,709
Total current assets	257,767	271,189
Marketable securities, non-current	22,359	28,008
Property and equipment, net	5,842	7,132
Right-of-use asset	57,536	63,956
Restricted cash	3,443	3,443
Other assets	2,655	2,723
Total assets	349,602	376,451
Current liabilities:
Accounts payable	1,328	1,446
Accrued expenses and other current liabilities	19,363	20,630
Deferred revenue, current	18,712	15,471
Operating lease liability, current	5,774	5,219
Total current liabilities	45,177	42,766
Deferred revenue, net of current	28,457	21,814
Operating lease liability, net of current	59,982	65,757
Total liabilities	133,616	130,337
Commitments and contingencies (See Note 6 and Note 9)
Stockholders’ equity:
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of December 31, 2024 and 2023, respectively	0	0
Common stock, par value of $0.0001 per share; 150,000,000 shares authorized, and 70,625,899 and 60,467,188 shares issued and outstanding as of December 31, 2024 and 2023, respectively	7	6
Additional paid-in capital	849,625	774,618
Accumulated other comprehensive income (loss)	53	(127)
Accumulated deficit	(633,699)	(528,383)
Total stockholders’ equity	215,986	246,114
Total liabilities and stockholders’ equity	$ 349,602	$ 376,451